A retrospective analysis of the causes of an adverse outcome in COVID-19 and HIV coinfection in the stage of secondary diseases

DOI: https://doi.org/10.29296/25877305-2023-02-08
Issue: 
2
Year: 
2023

Ya. Eremushkina(1), Candidate of Medical Sciences; T. Kuskova(1), Candidate
of Medical Sciences; S. Potekaeva(2), Candidate of Medical Sciences
1-A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry
of Health of Russia
2-Infectious Diseases Clinical Hospital Two, Moscow Healthcare Department

The increased incidence of COVID-19 and HIV coinfection and the changes in the structure of HIV infection mortality during the pandemic necessitate an analysis of the causes of adverse outcomes in co-infection. Objective. To retrospectively analyze deaths in patients with COVID-19 and HIV coinfection in the stage of secondary diseases. Subjects and methods. The investigation involved the medical records of 56 patients with laboratorily confirmed COVID-19 and HIV infection who were hospitalized in January to December 2021. Results. A retrospective analysis of the medical reports showed that bilateral polysegmental pneumonia of mixed etiologies was the cause of death in the majority cases of COVID-19 and HIV coinfection in the stage of secondary diseases. Along with pneumonia, multiple opportunistic diseases and conditions, which aggravated the course of the underlying disease, were identified in these patients. Various somatic diseases are one of the reasons for the severe course of the coinfection. Conclusion. Stage IVB HIV infection was diagnosed in the majority of deaths. Bilateral polysegmental pneumonia of mixed etiologies was the most common cause of death in patients with COVID-19 and HIV coinfection in the stage of secondary diseases.
Keywords: 
infectious diseases
COVID-19
HIV infection
fatal outcome
coinfection

References: 
  1. Dolgova N.N., Ryndich A.A., Suladze A.G. et al. Some clinical and epidemiological aspects of the course of COVID-19 in people living with HIV. Infectious Diseases: News, Opinions, Training. 2022; 11 (1): 41–6 (in Russ.). DOI: 10.33029/2305-3496-2022-11-1-41-46
  2. Belyakov N.A., Rassokhin V.V. Komorbidnye sostoyaniya pri VICh-infektsii. Chast' 1. Osnovy problemy. SPb: BMOTs, 2019; 184 р. (in Russ.).
  3. Kovalev E.V., Tverdokhlebova T.I., Karpushenko G.V. et al. Epidemiological situation of a new coronavirus infection (COVID-19) in the Rostov region: analysis and forecast. Medical Herald of the South of Russia. 2020; 11 (3): 69–78 (in Russ.). DOI: 10.21886/2219-8075-2020-11-3-69-78
  4. UNAIDS Data 2019. Joint United Nations Programme on HIV/AIDS, Geneva, 2020. URL: https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf
  5. EACS & BHIVA Statement on risk of COVID-19 for people living with HIV (PLWH). Wednesday 1 April, 2020.
  6. Guo W., Weng H.L., Bai H. et al. Quick Community Survey on the Impact of COVID-19 Outbreak for the Healthcare of People Living With HIV. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41 (5): 663–7. DOI: 10.3760/cma.j.cn112338-20200314-00345
  7. Eremushkina Ja., Kuskova T., Filippov P. et al. Features of the course of COVID-19 and HIV co-infection. Vrach. 2022; 33 (5): 18–23 (in Russ.). DOI: 10.29296/25877305-2022-05-04
  8. Zhao J., Liao X., Wang H. et al. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV. Clin Infect Dis. 2020; 71 (16): 2233–5. DOI: 10.1093/cid/ciaa408
  9. Carrico A.W., Horvath K.J., Grov C. et al. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS Behav. 2020; 24 (11): 3020–3. DOI: 10.1007/s10461-020-02854-w
  10. Yushchuk N.D. Infektsionnye bolezni: natsional'noe rukovodstvo. Pod red. N.D. Yushchuk, Yu.V. Vengerov. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2018; 1104 р. (in Russ.).
  11. Elektronnoe izdanie na osnove: Infektsionnye bolezni: natsional'noe rukovodstvo. Pod red. N.D. Yushchuk, Yu.V. Vengerov. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2018; 1104 р. (in Russ.).
  12. Kudlay D., Shirobokov Ya., Gladunova E. et al. Diagnosis of COVID-19. Methods and problems of virus SARS-CoV-2 detection under pandemic conditions. Vrach. 2020; 31 (8): 5–10 (in Russ.). DOI: 10.29296/25877305-2020-08-01
  13. Samorodskaya I., Klyuchnikov I. The problems of COVID-19 diagnosis and treatment: a clinical case example. Vrach. 2020; 31 (4): 19–25 (in Russ.). DOI: 10.29296/25877305-2020-04-04
  14. Antsiferov M.B., Aronov L.S., Belevskii A.S. et al. Klinicheskii protokol lecheniya bol'nykh novoi koronavirusnoi infektsiei (COVID-19), nakhodyashchikhsya na statsionarnom lechenii v meditsinskikh organizatsiyakh gosudarstvennoi sistemy zdravookhraneniya goroda Moskvy. Pod red. A.I. Khripun. M.: GBU «NIIOZMM DZM», 2020; 28 s. (in Russ.).
  15. Kravchenko A.V., Kuimova U.A., Kanestri V.G. et al. The clinical course of HIV/COVID-19 co-infection and approaches to its therapy. Epidemiology and Infectious Diseases. Current Items. 2021; 11 (4): 20–4 (in Russ.). DOI: 10.18565/epidem.2021.11.4.20-4
  16. Interim Guidance for COVID-19 and Persons with HIV Last Updated: April 21, 2020. URL: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/archive/2020_04_21_Interim%20Guidance%20for%20COVID.pdf
  17. US Centers for Disease Control and Prevention. What to Know About HIV and COVID-19. Atlanta, GA, 2020. URL: https://www.cdc.gov/hiv/basics/covid-19.html
  18. Kozlov V.A., Tikhonova E.P., Savchenko A.A. et al. Clinical immunology. A practical guide for infectious disease specialists. Krasnoyarsk: Polikor, 2021; 563 p. (in Russ.). DOI:10.17513/np.518